Navigation Links
A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy
Date:3/5/2008

s for clinical application. Pure research and clinical research should be kept separate from one another. Embryonic stem cells are necessary so that we can gain a better understanding of the programmability of cells."

About Blasticon Biotechnologische Forschung GmbH

Blasticon is a biotechnology company that is active in the fields of cellular medicine and in vitro diagnostics. Blasticon has at its disposal a patented technology that enables it to turn monocytes (mature white blood cells) from extracted blood into PCMO (programmable cells of monocytic origin = stem-cell-like human cells) and to differentiate them into different functional cells for diverse applications in diagnostics and therapy. The company was founded in 2002.

Contact:

PRint Agentur fur Offentlichkeitsarbeit GmbH

Katja Schmidt

Ottobrunner Strasse 26

82008 Unterhaching

Germany

Telephone: +49-89-66532-1280

Telefax: +49-89-66532-1115

Email: katja.schmidt@heye.de


'/>"/>
SOURCE Blasticon Biotechnologische Forschung GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Germany Hosts World Leading Medical Industry Fair
2. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
3. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
4. ROBODOC(R) Emerges as a Curexo Technology Company at Upcoming Orthopaedic Surgeons Conference in San Francisco
5. Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations
6. National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000
7. European Company NovaSecta Joins First Chinese CRO Service Alliance for Drug Discovery Solutions
8. Nastech Pharmaceutical Company Implements Additional Workforce Reduction as Part of Previously Announced Corporate Restructuring
9. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
10. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
11. Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014  United Therapeutics Corporation (NASDAQ: ... well as changes to Martine Rothblatt , Ph.D,s ... United Therapeutics announced the promotion of ... Officer and David Zaccardelli , Pharm.D. to Executive ... these promotions, Dr. Rothblatt,s title will change from Chairman ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce that ... with PVM technology , is now available. The ... tool continuously captures high-resolution images under a wide ... prepares a report pairing the most relevant images ... This compelling blend of high resolution images and ...
(Date:12/15/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology,  today celebrated continued ... its exVive3D TM Human Liver Tissue.  The ... commercial release on November 18, has been recognized ... awards for innovation. Most recently, on ...
Breaking Biology Technology:United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3
... 11 /PRNewswire-FirstCall/ - MIGENIX Inc. ("MIGENIX"),announced today that ... ("DJohnson"), a significant shareholder of MIGENIX, that will ... shareholders scheduled for,October 31, 2008. As part of ... board of directors from seven members to five ...
... 5:00 p.m. EDT -, VALENCIA, Calif., Aug. 11 ... results for the second,quarter ended June 30, 2008., ... were $80.9,million, compared to $75.4 million for the second ... research and development,(R&D) expenses which totaled $67.6 million for ...
... administrator for the,HealthShares(TM) Indexes, a series of 20 ... announced the following,change effective on the opening of ... Germany: BIO) will replace Speedel Holding AG (SWX,Switzerland: ... AG is being acquired by Novartis AG (SWX, ...
Cached Biology Technology:Migenix averts proxy contest; reaches agreement with DJohnson holdings 2Migenix averts proxy contest; reaches agreement with DJohnson holdings 3Migenix averts proxy contest; reaches agreement with DJohnson holdings 4MannKind Corporation Reports Second Quarter Financial Results 2MannKind Corporation Reports Second Quarter Financial Results 3MannKind Corporation Reports Second Quarter Financial Results 4MannKind Corporation Reports Second Quarter Financial Results 5MannKind Corporation Reports Second Quarter Financial Results 6Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index 2
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) ... Market in India 2015-2019" report to their ... in this market is the adoption of multimodal ... one characteristic of an individual for verification and ...
(Date:12/10/2014)... 8, 2014 You,ve been here before: you desperately ... remember your password, site key or the answer to your ... grade teacher? Today, Hoyos Labs , ... that will finally put an end to the frustration that ... . 1U leverages a user,s smartphone to acquire his ...
(Date:12/10/2014)... 2014 CIE San Diego has launched an ... connective tissue that enhances care coordination among social service ... client-level information; earned a second $1 million grant from ... seniors aging in community and; will be recognized as ... th 4-6p. CIE San Diego today ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... Germans Trias i Pujol Health Sciences Research Institute (IGTP) and ... genetic biomarker to detect Lewy body dementia (LBD), a disease ... in 20% of cases and differentiates one of the sub-groups ... lead to more precise diagnosis and treatment. Lewy body ...
... research from the University of Exeter and King,s College London ... in the contaminated waters of the River Hayle in Cornwall ... to fish from unpolluted sites. The team believe this is ... research was funded by NERC and the Salmon and Trout ...
... , July 25, 2013 The following statement is being issued ... LLP regarding the Pacific Biosciences Securities Litigation SUPERIOR COURT OF ... SAN MATEO IN RE PACIFIC BIOSCIENCES OF ... ACTIONS. Case No. CIV509210 SUMMARY NOTICE OF PROPOSED SETTLEMENT OF CLASS ACTION ...
Cached Biology News:Discovered a genetic biomarker that detects Lewy body dementia 2Study investigates extraordinary trout with tolerance to heavily polluted water 2Study investigates extraordinary trout with tolerance to heavily polluted water 3Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation 2Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation 3Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation 4
... assay for monitoring acetylcholinesterase (AChE) activity. This ... than 5 min), non-radioactive and easy to ... the natural substrate, acetylcholine. A series of ... active AChE into a change in luminescence. ...
... The Pulsed Dynamic Focusing MALDI (PDF-MALDI) ... for samples that do not need online ... Ion Trap LC/MS and Agilents powerful Spectrum ... for fast analysis of 2D gel-spot digests. ...
Rabbit polyclonal to Vitronectin ( Abpromise for all tested applications). Antigen: Full length Vitronectin protein (Mouse). Entrez Gene ID: 7448 Swiss Protein ID: P04004...
... Genie is an all-in-one rotator/rocker with ... five different mixing motions: rotating, ... well as a combination of all ... portion of the Vibraotme Roto-Shake Genie ...
Biology Products: